Nel ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nel ASA with three other
miscellaneous service companies in Europe:
Circassia Pharmaceuticals PLC
of the United Kingdom
sales of £10.80 million [US$13.17 million]
of which 95%
Pharming Group NV
of the Netherlands
(10.83 million Euro [US$11.80 million]
based in Belgium
(11.20 million Euro [US$12.20 million]
of which 100%
was Royalty Income).
Sales increased substantially in 2015:
Nel ASA reported sales of NOK 99.93 million (US$12.06 million)
December of 2015.
increase of 728.1%
versus 2014, when the company's sales were NOK 12.07 million.
This was the third consecutive year of growth at Nel ASA.